Bora Pharmaceuticals Co., LTD. (TWSE:6472) agreed to acquire remaining 34.3% stake in Bora Biologics Co., Ltd. for TWD 1.4 billion on April 12, 2024. As per the transaction, Bora Pharmaceuticals Co., LTD. will issue 1 share for 14.205 shares of Bora Biologics Co., Ltd. Bora Pharmaceuticals Co., LTD. expected to issue 1.7 million shares for the transaction. The transaction is approved by board of directors of Bora Biologics Co., Ltd. The transaction is expected to close on July 26, 2024.